The Use of Nasal Phenylephrine in Infants With Bronchiolitis

Akron Children's Hospital50 enrolled

Overview

Drops of either saline or phenylephrine are placed in the nose of infants less than 12 months of age to determine if it helps them to breathe easier.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

DOUBLE

Enrollment

Conditions

Bronchiolitis

Interventions

PhenylephrineDRUG

Eligibility

Sex: ALLMin age: 4 WeeksMax age: 12 Months

Medical Language ↔ Plain English

Inclusion Criteria: * Age 4 weeks to 12 months; admitting diagnosis of bronchiolitis; admitted to hospital's bronchiolitis pathway, admitted during weekdays, need for nasal suctioning. Exclusion Criteria: * Congenital heart disease, history of hypertension, previous wheezing, prior use of inhaled corticosteroids, gestational age at birth of \<34 weeks.

Outcomes

Primary Outcomes

Respiratory Distress Assessment Index at 5 minutes, 60 minutes, and 180 minutes.

Secondary Outcomes

Respiratory rate, oxygen saturation and use of supplemental oxygen at 5, 60, and 180 minutes.

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.